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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the benefits and harms of rigid dressings versus soft dressings for treating transtibial amputations.
B A C K G R O U N D
Description of the condition
Lower limb amputation can result from non-traumatic causes (e.g.
dysvascular disease, malignancy and congenital deficiencies) or
traumatic causes (e.g. war injuries and work accidents) (Varma
2014; Ziegler-Graham 2008). Amongst these causes, dysvascular
disease is most common and includes diseases such as diabetes and
peripheral vascular disease (Varma 2014; Ziegler-Graham 2008).
The incidence of lower limb amputation is estimated to be 24 per
100,000 in the USA (Moxey 2011), and 26 per 100,000 in the
UK (Ahmad 2014). These estimates increase in people with dia-
betes, and estimates range from 410 to 3100 per 100,000 in the
USA and from 147 to 248 per 100,000 in the UK (Moxey 2011).
Trauma is the second most common cause of limb loss (Varma
2014; Ziegler-Graham 2008), and accounts for 16% of amputa-
tions in the USA (Tintle 2010), and 7% to 9% of amputations
in the UK (Perkins 2012). Approximately half of all lower limb
amputations are transtibial (below the knee) amputations (Curran
2014; Fortington 2013; Kayssi 2015; Moxey 2010; Zayed 2014).
Poor outcomes are commonly reported post-lower limb ampu-
tation. High mortality rates have been reported in patients with
non-traumatic amputations, with almost 50% dying within one
year and 70% dying within three years, mostly due to underlying
co morbidities (e.g. heart failure, renal failure, cancer and chronic
obstructive pulmonary disease) (Jones 2013). The rate of hospital
readmission within 30 days ranges from 10% to 30%, with a large
proportion readmitted due to wound complications and stump
revisions (Curran 2014; Kayssi 2015; Ries 2015). In patients with
traumatic amputations, half have been reported to have substantial
disability at two-year and seven-year follow-up (MacKenzie 2004;
MacKenzie 2005). Rehospitalisation rates were similar at less than
30%, with 34% developing wound infections and 15% requiring
revision (Harris 2009). Consequently, the cost of acute and post-
acute care of an initial episode of amputation is high, costing more
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than USD 8.3 billion yearly in the USA (Ma 2014). In the UK,
up to GBP 985 million is spent on care related to foot ulcers and
amputations (Hex 2012).
Description of the intervention
Two main types of dressings can be applied after a transtibial am-
putation. These dressings include soft and rigid dressings. These
dressings differ from local wound dressings (e.g. hydrogel dress-
ings, negative wound therapy, honey, aloe vera) in that they are
applied with a degree of compression in order to reduce stump
swelling in preparation for prosthetic fitting in transtibial amputa-
tions (Choudhury 2001; Smith 2003). Soft dressings (e.g. elastic
or crepe bandages) are the conventional choice of dressings due to
their low cost and easy applicability (Choudhury 2001). However,
rigid dressings have grown in popularity due to the belief that a
hard exterior provides greater compression, greater reduction in
swelling and hence faster wound healing and shorter time to pros-
thetic fitting (Churilov 2014; Nawijn 2005). Rigid dressings are
the intervention of interest in this systematic review and include
the following variations (Smith 2003);
Non-removable rigid dressings
These are multi-layered dressings made out of gauze pads and ban-
dages, cotton/woollen/synthetic fibre stump socks and a plaster
of Paris cast. Dressings are moulded up to the thigh level of the
stump with the knee immobilised in full extension. The earliest
report of their use is in 1961 (Baker 1977; Golbranson 1968).
These dressings are sometimes combined with an immediate post-
operative prosthesis (Johannesson 2010). Plaster of Paris casts are
also sometimes replaced with a prefabricated plastic dressing held
by neoprene and Velcro straps (Sumpio 2013).
Removable rigid dressings
These are similar to non-removable rigid dressings except they
do not include the knee so it is free to flex. Use of a removable
rigid dressing was first reported in 1979 (Wu 1979). The main
advantages of a removable rigid dressing over a non-removable
rigid dressing is that it allows frequent observation of the wound
and does not require another cast to be made. If stump volume
decreases, socks can be added to the cast and the cast placed back on
the stump (Wu 1979). The removable rigid dressings may increase
susceptibility to knee flexion contractures because the knee is not
held in extension. In order to keep the knee extended and minimise
the chances of knee flexion contractures, the use of pouches on
patients’ wheelchairs (Hughes 1998), or custom-made removable
bivalved rigid shells have also been suggested (Duwayri 2012).
Plaster of Paris casts are also sometimes replaced with a fibreglass/
synthetic cast for a lighter cast (Duwayri 2012; Taylor 2008).
Immediate postoperative prostheses
These allow for early weight-bearing on the stump. These pros-
theses can vary in terms of their top or bottom parts. The top
part surrounding the stump can come in either a custom-made
plaster of Paris cast (Burgess 1968; Condon 1969; Folsom 1992),
or prefabricated pneumatic air bladder/air splint (Pinzur 1989;
Schon 2002), or prefabricated plastic dressing held by neoprene
and Velcro straps (Ali 2013). The bottom part that is in contact
with the ground can be either a metal cylinder (Pinzur 1989), or
an adjustable aluminium pylon attached to an artificial foot (Ali
2013; Burgess 1968; Condon 1969; Folsom 1992; Schon 2002).
Others
These include combinations of the above (e.g. non-removable rigid
dressings and immediate postoperative prostheses) or dressings
and prostheses that are not yet described. These include the Ster-
ishield Controlled Environment Unit (CEU) and semi-rigid dress-
ings. The CEU consists of a sterile transparent pneumatic plastic
cylinder, which allows the flow of warm filtered air through the
system but does not allow weight-bearing (Ruckley 1986). Semi-
rigid dressings consist of a bandage imbedded with Unna paste
developed by a dermatologist in 1883 to treat ulcers. The Unna
paste is made of zinc oxide, calamine, gelatin and glycerine and
forms a semi-rigid inextensible dressing (MacLean 1994; Wong
2000).
How the intervention might work
The main postulated benefits of rigid dressings over soft dressings
are:
• greater reduction in swelling via application of more
consistent pressure around the stump (Duwayri 2012;
Golbranson 1968); and
• greater protection of the stump from trauma due to the
hard surface of a rigid dressing (Duwayri 2012; Wu 1979).
These factors are believed to lead to faster wound healing, reduced
risk of wound infection/breakdown, reduced pain, shorter time
to prosthetic fitting and reduced length of stay in the hospital
(Churilov 2014; Schon 2002).
Why it is important to do this review
There is uncertainty about the most appropriate and effective type
of dressings following transtibial amputations. Several reviews have
been conducted to investigate the efficacy of rigid dressings in
improving outcomes in transtibial amputations though only two
were systematic reviews (Churilov 2014; Nawijn 2005). Of these
two systematic reviews, one review was published more than a
decade ago (Nawijn 2005), and one only investigated the efficacy
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of rigid dressings on one outcome (i.e. time from amputation to
prosthetic fitting) (Churilov 2014). Despite being the first meta-
analysis to be conducted on the literature, Churilov 2014 drew
the conclusion to support rigid dressings without consideration of
the inconsistency and imprecision of the results from the studies
included in the systematic review. Several amputee care guidelines
have also recommended the use of rigid dressings for transtibial
amputations (BACPAR 2012; US Dept of Veterans Affairs 2008),
though these recommendations are largely based on poorly con-
ducted randomised controlled trials (RCTs), observational stud-
ies, case-control studies and retrospective audits. Due to the skep-
ticism surrounding the quality of evidence on rigid dressings and
the belief that rigid dressings can lead to wound breakdowns in
some patients with poor skin integrity, there remains wide vari-
ation in practice concerning dressings in transtibial amputations
(Barnes 2014; Choudhury 2001). It is therefore important to con-
duct a comprehensive and rigorous systematic review to summarise
recent evidence on the benefits and harms of rigid dressings in
transtibial amputations.
O B J E C T I V E S
To assess the benefits and harms of rigid dressings versus soft dress-
ings for treating transtibial amputations.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs. The lat-
ter includes studies with quasi-randomised allocation procedures,
such as alternation, hospital record number or date of birth
(Lefebvre 2011).
Types of participants
People of all ages with transtibial amputations due to all causes in-
cluding dysvascular disease (diabetes, peripheral vascular disease),
trauma and cancer.
Types of interventions
• Rigid dressings (intervention), which include non-
removable rigid dressings, removable rigid dressings, immediate
postoperative prostheses and others;
• soft dressings (comparison), which include crepe bandaging
and elastic/compression bandaging.
Types of outcome measures
Timing of outcome measures
Outcomes could be obtained at any time point following ampu-
tation. We will group outcomes according to the time since am-
putation:
• short-term outcomes: outcomes obtained less than one
month since amputation;
• medium-term outcomes: outcomes obtained between one
to three months of amputation;
• long-term outcomes: outcomes obtained after three months
of amputation.
We will present dichotomous and continuous outcomes as short-
term, medium-term and long-term outcomes. We will present
time-to-event outcomes at the median or mean follow-up reported
by the authors. We will use our judgement as to whether statistical
pooling within these outcomes is appropriate.
Primary outcomes
• Wound healing measured as time from amputation to
wound healing and proportion of wounds healed;
• complications/adverse events measured as proportion of
skin-related complications/adverse events (e.g. wound infections/
breakdowns/stump revisions/further amputations/pressure
areas), proportion of non skin-related complications/adverse
events (e.g. deaths, chest infections, falls, pain) and severity of
pain on the visual analogue scale.
Secondary outcomes
• Prescription of prosthetics measured as time from
amputation to first prosthetic fit/cast;
• physical function measured as time to independent
ambulation, proportion of participants mobilising independently
and functional assessment scales (e.g. Functional Independence
Measure scale);
• length of hospital stay measured as time from hospital
admission to discharge;
• patient comfort measured with a validated scale used to
measure patient’s ease, comfort or satisfaction with the dressing;
• quality of life data measured with generic or wound-specific
questionnaires;
• cost measured as any cost relating to dressings or other
resources (e.g. personnel costs).
• swelling measured as girth measurements or any other
measures of stump volume reported by study authors. (We note
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that swelling is a potential surrogate outcome for other outcomes
such as wound healing, physical function and length of hospital
stay. Conclusions regarding efficacy of rigid dressings will not be
based on swelling).
We anticipate that study authors will define wound healing in
different ways (Gethin 2015). We will not try to enforce a single
definition of wound healing across all trials but instead we will
extract data according to each authors’ definition of wound heal-
ing. We will also align our methods of data extraction and data
analysis/synthesis of wound outcomes with previous Cochrane
systematic reviews on wound healing for consistency (Dumville
2015a; Dumville 2015b). We have covered these methods further
in the sections on Data extraction and management, Measures of
treatment effect, Unit of analysis issues and Data synthesis.
Search methods for identification of studies
Electronic searches
We will search the following electronic databases for relevant stud-
ies:
• the Cochrane Wounds Specialised Register (to present);
• the Cochrane Central Register of Controlled Trials
(CENTRAL) (the Cochrane Library, latest issue);
• Ovid MEDLINE (1946 to present);
• Ovid MEDLINE (In-Process & Other Non-Indexed
Citations) (latest issue);
• Ovid Embase (1974 to present);
• EBSCO CINAHL Plus (1937 to present);
• Ovid AMED (1985 to present);
• PEDro (www.pedro.org.au) (to present).
We have presented the draft search strategy for CENTRAL in
Appendix 1. We will adapt this strategy to search the other
databases we have listed above. We will combine the Ovid MED-
LINE search with the Cochrane Highly Sensitive Search Strategy
for identifying randomised trials in MEDLINE: sensitivity- and
precision-maximising version (2008 revision) (Lefebvre 2011).
We will combine the Embase search with the Ovid Embase ran-
domised trials filter terms developed by the UK Cochrane Centre
(Lefebvre 2011). We will combine the CINAHL search with the
randomised trials filter terms developed by the Scottish Intercolle-
giate Guidelines Network (SIGN 2015). We will not restrict stud-
ies with respect to language, date of publication or study setting.
Searching other resources
In order to identify further published, unpublished and ongoing
studies, we will also:
• search the reference lists of relevant studies and reviews
identified in prior searches;
• search the following clinical trial registries:
ClinicalTrials.gov, the World Health Organization (WHO)
International Clinical Trials Registry Platform (ICTRP);
• use the Cited Reference Search facility on
ThomsonReuters Web of Science;
• contact relevant individuals and organisations for
unpublished and ongoing studies;
• search the grey literature using Open Grey and Google
Scholar.
Data collection and analysis
Selection of studies
Two review authors (LKK and LG) will independently screen ti-
tles and abstracts to determine eligibility of potential studies. We
will resolve any disagreements through discussion and the third
review author (LH) will arbitrate if there is still disagreement. We
will obtain full-text publications of the potentially eligible studies
and two review authors (LKK and LG) will independently screen
these publications for inclusion. We will exclude studies that do
not meet the inclusion criteria at this point. We will record the
excluded studies and their reasons for exclusion in the ’Character-
istics of excluded studies’ table. If we require more information to
determine the eligibility of studies, we will contact the investiga-
tors of relevant studies for more information. If there are disagree-
ments regarding the eligibility of the full-text publications, we will
consult a third review author (LH) to resolve these disagreements.
We will complete a Preferred Reporting Items for Systematic Re-
views and Meta-Analyses (PRISMA) flow-chart to summarise this
process (Liberati 2009). We will use the reference management
software EndNote (EndNote 2014) to manage the records we re-
trieve in the selection process.
Data extraction and management
Two review authors (LKK and LG) will independently extract data
on study characteristics and outcomes from the included studies
using a data extraction form. The categories of data extracted will
include:
• methods: study design, method of randomization, country
of study, type of incision (skew flap or long posterior flap), care
setting (acute/surgical or rehabilitation);
• participants: sample size (by group), number of dropouts
(by group), inclusion criteria, exclusion criteria, baseline
characteristics of participants (age, gender, traumatic or non-
traumatic amputation and skin integrity (e.g. measured with the
NPUAP Pressure Ulcer Stages/Categories), by group if provided);
• interventions: type of dressing, time to first application of
dressing, duration of dressing (hours per day, days/weeks),
comparator therapy;
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• outcomes: primary outcomes (with definitions), secondary
outcomes (with definitions), other outcomes (with definitions),
timing of outcomes (short-term, medium-term or long-term
with specific time frames);
• notes: publication status, funding of trials and conflicts of
interest.
We will use a piloted data extraction form. We will resolve all
disagreements by discussion or arbitration with the third review
author (LH). One review author will enter the extracted data into
Review Manager (RevMan) and a second author will cross-check
the data to ensure accuracy (RevMan 2014). We will screen for
potential duplicate publications by cross-checking authors’ names,
year of publication and journal titles. We will download and assess
full-text copies of the studies if we remain uncertain whether or
not the publication is a duplicate.
If several measures of a similar outcome (e.g. wound healing) are
present in a study, we will extract all data and list them in a sum-
mary of study outcomes table, but we will only enter the preferred
data type into the meta-analyses. The preferred data type will be
time-to-event outcomes, followed by dichotomous outcomes and,
lastly, continuous outcomes. Time-to-event outcomes (e.g. time
from amputation to wound healing) and dichotomous outcomes
(e.g. proportion of wounds healed) are preferred as these are likely
to have more clinical relevance than continuous outcomes (e.g.
wound size). Time-to-event outcomes are preferred over dichoto-
mous outcomes as they allow more comparisons between studies
with different follow-up time points and are less prone to selective
outcome reporting bias, which can occur in studies with dichoto-
mous outcomes since investigators can intentionally select time
points that show the least or greatest difference between groups
(Tierney 2007).
Assessment of risk of bias in included studies
Two review authors will independently rate the risk of bias in
each included study using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011a).
We will assess the risk of bias using the following domains (see
Appendix 2):
• random sequence generation;
• treatment allocation;
• blinding of participants, care providers and outcome
assessors;
• incomplete outcome data;
• selective outcome reporting;
• other potential sources of bias (e.g. industry funding).
We will rate each potential source of bias as either high, low or
unclear in each included study and will provide justification for
our rating in the ’Risk of bias’ table. If there is ambiguity, we
will contact the study investigators for clarification. We will also
summarise the overall risk of bias of all studies for each domain and
for each outcome so that the final results for outcome measures
will be deemed as either at high, low or unclear risk of bias.
Measures of treatment effect
For time-to-event data (e.g. time from amputation to wound heal-
ing), we will calculate results as hazard ratios using the ‘O-E’ (ob-
served minus expected events) and ‘V’ (logrank variance) statis-
tics derived from number of events and times to events in control
and interventions groups (Tierney 2007). If these statistics are not
readily available, we will refer to further guidance (Tierney 2007),
as recommended in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011a). If study authors provide a mean
or median time to outcomes and clearly state that all outcomes
(e.g. wound healing) were achieved, we will pool these data in a
meta-analyses as continuous data. If it is unclear that all outcomes
were achieved, we will document but not pool the data. We will
use the generic inverse variance method for all analyses in RevMan
(RevMan 2014).
For dichotomous data (e.g. proportion of wounds healed), we will
present results as risk ratios (RRs) with 95% confidence intervals
(CIs). We will also calculate the number needed to treat for an
additional beneficial outcome (NNTB) and number needed to
treat for an additional harmful outcome (NNTH) from the risk
difference for easier interpretability of results.
For continuous data (e.g. wound sizes, girth measurements, pain
scores), we will calculate results as means or changes in mean scores
with 95% CIs. If studies use different scales to measure the same
outcome, we will report standardised mean differences with 95%
CIs. If ordinal data are present, we will analyse these as continuous
data.
Unit of analysis issues
If studies have more than one intervention group (e.g. non-remov-
able rigid dressings and removable rigid dressings) or more than
one control group (e.g. crepe bandaging and elastic bandaging),
we will combine the groups such that we make only a single pair-
wise comparison, i.e. we compare data from both non-removable
rigid and removable rigid dressing groups against data from crepe
bandaging and elastic bandaging groups. The unit of analysis will
be the participant. In the event that studies have participants with
double amputations and treatment was carried out on both legs,
we will adjust for intra-patient correlation (intra-cluster correla-
tion) in the effect estimates of relevant outcome measures.
Dealing with missing data
If information is missing on the methods or results (e.g. data from
drop-outs, data reported at baseline but not at follow-up, statis-
tics such as standard deviations (SDs)), we will contact study in-
vestigators to request missing information. We will contact study
investigators via email addresses provided in the publication or by
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searching the staff directory of authors’ affiliated organisations as
stated in the publication. If we are unable to obtain the missing
information, we will estimate the missing SD values according to
methods described in the Cochrane Handbook for Systematic Re-
views of Interventions, Section 16.1.3 (Higgins 2011b). We will
perform sensitivity analyses to determine the influence of missing
data on the results. We will discuss findings of the review based
on the results of our sensitivity analyses.
Assessment of heterogeneity
Before combining studies in meta-analyses, we will check for clin-
ical and statistical heterogeneity. We will base judgements about
clinical heterogeneity on clinical reasoning after reviewing partici-
pant, intervention and outcome characteristics of studies. We will
base judgements about statistical heterogeneity on the Chi² test
and the I² statistic values (Higgins 2011a).
Assessment of reporting biases
We will minimise reporting biases by searching several databases
and clinical trial registries. We will ensure that we do not enter
data in duplicate publications twice into the meta-analysis. If there
are more than 10 studies for each outcome, we will create funnel
plots and look for signs of asymmetry. If there are fewer than 10
studies for each outcome, we will summarise the findings of the
review based on the results of our sensitivity analyses.
Data synthesis
We will use RevMan to conduct our analyses (RevMan 2014). We
will conduct a meta-analysis if the included studies do not demon-
strate substantial clinical heterogeneity, i.e. participant, interven-
tion and outcome characteristics of studies are similar enough to
be pooled. Also, we will investigate statistical heterogeneity. We
will conduct a meta-analysis if there is no substantial statistical
heterogeneity, i.e. the Chi² test yields a P value greater than 0.1
and the I² statistic is less than 50%) (Higgins 2011a). In deciding
between a fixed-effect or a random-effects model, we will use a
random-effects model if there is a sufficient number of included
studies and the I² statistic value is greater than 0%. We will adopt
the conservative approach of using a random-effects model with
any signs of heterogeneity (i.e. I² statistic value is greater than 0%)
due to the high risk of undetected heterogeneity which can oc-
cur with few included studies in a meta-analysis (Kontopantelis
2013).
’Summary of findings’ tables
We will present the main results of the review in ’Summary of find-
ings’ tables using GRADEpro GDT (GRADEpro GDT 2015).
These tables present key information concerning the quality of
the evidence, the magnitude of the effects of the interventions ex-
amined and the sum of the available data for the main outcomes
(Schünemann 2011a). The ’Summary of findings’ tables also in-
clude an overall grading of the evidence related to each of the main
outcomes using the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach. The GRADE
approach defines the quality of a body of evidence as the extent
to which one can be confident that an estimate of effect or associ-
ation is close to the true quantity of specific interest. The quality
of a body of evidence involves consideration of within-trial risk
of bias (methodological quality), directness of evidence, hetero-
geneity, precision of effect estimates and risk of publication bias
(Schünemann 2011b). We plan to present the following outcomes
in the ’Summary of findings’ tables; wound healing, complica-
tions/adverse events, physical function, length of hospital stay, pa-
tient comfort, quality of life and cost.
Subgroup analysis and investigation of heterogeneity
We will investigate heterogeneity using the methods described
in Section 9.6 of the Cochrane Handbook (Deeks 2011). We
will perform subgroup analyses to determine whether the size of
treatment effects are influenced by the following:
• type of rigid or soft dressings (e.g. non-removable rigid
dressings vs crepe bandaging, removable rigid dressings vs crepe
bandaging, non-removable rigid dressings vs elastic bandaging,
removable rigid dressings vs elastic bandaging).
We will only perform subgroup analyses if there are a minimum
of 10 studies included in the meta-analysis.
Sensitivity analysis
We will perform sensitivity analyses to determine if the results
are robust to arbitrary decisions that we make during the review
process. We also plan to assess whether these results differ when
we only consider studies at low risk of bias versus studies of high
and unclear risk of bias in specific methodological aspects of the
study. These methodological aspects include:
• randomisation (true random versus quasi-random);
• concealed allocation (concealed versus non-concealed);
• blinding of assessors (blinding versus no blinding); and
• drop-out rate (greater than 15% versus less than 15%).
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A P P E N D I C E S
Appendix 1. The Cochrane Central Register of Controlled Trials (CENTRAL) provisional search
strategy
#1 MeSH descriptor: [Amputation] explode all trees
#2 MeSH descriptor: [Amputation Stumps] explode all trees
#3 MeSH descriptor: [Amputees] explode all trees
#4 MeSH descriptor: [Lower Extremity] this term only
#5 ((transtibia* or trans-tibia*) near/3 amput*):ti,ab,kw
#6 ((“below knee” or below-knee) near/3 amput*):ti,ab,kw
#7 ((low* next limb*) near/3 amput*):ti,ab,kw
#8 ((low* next extremit*) near/3 amput*):ti,ab,kw
#9 BKA:ti,ab,kw
#10 amput* next stump*:ti,ab,kw
#11 residua* next limb*:ti,ab,kw
#12 {or #1-#11}
#13 MeSH descriptor: [Bandages] explode all trees
#14 MeSH descriptor: [Artificial Limbs] explode all trees
#15 MeSH descriptor: [Casts, Surgical] explode all trees
#16 MeSH descriptor: [Splints] explode all trees
#17 ((rigid or plastic* or compress* or unna) near/3 (dressing* or bandage*)):ti,ab,kw
#18 gauze:ti,ab,kw
#19 (sock* near/5 (amput* or stump*)):ti,ab,kw
#20 (prosth* near/3 (amput* or stump* or transtibia* or trans-tibia* or “below knee” or below-knee or low* next limb* or low* next
extremit* or residua* next limb*)):ti,ab,kw
#21 ((plaster or fibreglass or fiberglass or plastic* or surgical or synthetic*) near/3 cast*):ti,ab,kw
#22 splint*:ti,ab,kw
#23 {or #13-#22}
#24 {and #12, #23} in Trials
Appendix 2. Cochrane ’Risk of bias’ assessment tool
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
There is insufficient information about the sequence generation process provided to permit a judgement of low or high risk of bias.
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2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomization);
sequentially-numbered drug containers of identical appearance; sequentially-numbered, opaque, sealed envelopes.
High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: use of an open random allocation schedule (e.g. a list of random numbers); assignment envelopes without appropriate
safeguards (e.g. envelopes were unsealed, non-opaque or not sequentially numbered); alternation or rotation; date of birth; case record
number; any other explicitly unconcealed procedure.
Unclear
Insufficient information provided to permit a judgement of low or high risk of bias. This is usually the case if the method of concealment
is not described, or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is
described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following:
• no blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by
lack of blinding;
• blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken;
• either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others unlikely to introduce bias.
High risk of bias
Any one of the following:
• no blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding;
• blinding of key study participants and personnel attempted, but likely that the blinding could have been broken;
• either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
Either of the following:
• insufficient information to permit judgement of low or high risk of bias;
• the study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following:
• no missing outcome data;
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• reasons for missing outcome data are unlikely to be related to true outcome (for survival data, censoring unlikely to be
introducing bias);
• missing outcome data are balanced in numbers across intervention groups, with similar reasons for missing data across groups;
• for dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is not enough to
have a clinically relevant impact on the intervention effect estimate;
• for continuous outcome data, a plausible effect size (difference in means or standardised difference in means) among missing
outcomes is not enough to have a clinically relevant impact on the observed effect size;
• missing data have been imputed using appropriate methods.
High risk of bias
Any one of the following:
• reason for missing outcome data are likely to be related to the true outcome, with either an imbalance in numbers or reasons for
missing data across intervention groups;
• for dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is enough to induce
clinically relevant bias in the intervention effect estimate;
• for continuous outcome data, a plausible effect size (difference in means or standardised difference in means) among missing
outcomes is enough to induce a clinically relevant bias in the observed effect size;
• ’as-treated’ analysis done with a substantial departure of the intervention received from that assigned at randomisation;
• potentially inappropriate application of simple imputation.
Unclear
Either of the following:
• insufficient reporting of attrition/exclusions to permit a judgement of low or high risk of bias (e.g. number randomised not
stated, no reasons for missing data provided);
• the study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Either of the following:
• the study protocol is available and all of the study’s prespecified (primary and secondary) outcomes that are of interest in the
review have been reported in the prespecified way;
• the study protocol is unavailable but it is clear that the published reports include all expected outcomes, including those that
were prespecified (convincing text of this nature may be uncommon).
High risk of bias
Any one of the following:
• not all of the study’s prespecified primary outcomes have been reported;
• one or more primary outcomes is/are reported using measurements, analysis methods, or subsets of the data (e.g. subscales) that
were not prespecified;
• one or more reported primary outcomes was/were not prespecified (unless clear justification for their reporting is provided, such
as an unexpected adverse effect);
• one or more outcomes of interest in the review is/are reported incompletely so that they cannot be entered in a meta-analysis;
• the study report fails to include results for a key outcome that would be expected to have been reported for such a study.
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Unclear
Insufficient information provided to permit a judgement of low or high risk of bias. It is likely that most studies will fall into this
category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study either:
• had a potential source of bias related to the specific study design used;
• has been claimed to have been fraudulent; or
• had some other problem.
Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or
• insufficient rationale or evidence that an identified problem will introduce bias.
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